You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft-versus-host-disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in United States (Ofatumumab)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Phoenix, Arizona
  • +3 more
Sep 30, 2022

Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

Active, not recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 29, 2022

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

Recruiting
  • Chronic GVHD
  • Bethesda, Maryland
  • +1 more
Jan 26, 2023

Transplant-Related Disorder Trial in Tianjin (Ruxolitinib)

Recruiting
  • Transplant-Related Disorder
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jan 28, 2023

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

GVHD Trial in Chicago (Expressive Writing)

Not yet recruiting
  • Graft Versus Host Disease
  • Expressive Writing
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
Jan 12, 2023

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

Chronic GVHD Trial (Belumosudil)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • (no location specified)
Jan 5, 2023

Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

Recruiting
  • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
  • topical ruxolitinib 1.5% cream
  • Topical vehicle/moisturizer cream
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 20, 2022

Evaluation of the Impact of Reduced Immunosuppression

Enrolling by invitation
  • Graft Vs Host Disease
  • Dallas, Texas
    Methodist Dallas Medical Center
Dec 20, 2022

GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

Terminated
Has Results
  • Graft Versus Host Disease
  • +2 more
  • Ruxolitinib 1.5% cream
  • vehicle cream
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2022

Transplant-Related Disorder Trial (Ruxolitinib)

Not yet recruiting
  • Transplant-Related Disorder
  • (no location specified)
Oct 25, 2022

Dendritic Cells in Acute or Chronic Skin Graft Versus Host

Recruiting
  • Acute Graft-versus-host Disease
  • +3 more
  • Skin punch biopsy
  • Peripheral blood draw
  • Saint Louis, Missouri
    Washington University School of Medicine
May 31, 2022

Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

Not yet recruiting
  • Graft Vs Host Disease
  • Vandoeuvre Les Nancy, France
    CHRU de Nancy
Nov 10, 2023

Clinical and Biological Factors Determining Outcomes in Chronic

Recruiting
  • Chronic Graft vs Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)

    Recruiting
    • Acute-graft-versus-host Disease
    • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Mar 31, 2022

    Acute Graft-versus-Host Disease

    Active, not recruiting
    • Acute Graft-versus-Host Disease
    • Allogeneic Stem Cell Transplant
    • Blood samples
    • Columbus, Ohio
      Ohio State University Medical Center
    Apr 18, 2022

    GVHD Trial in Nantes (drug, radiation, other)

    Terminated
    • Graft Versus Host Disease
    • Nantes, France
      Nantes Uh
    Jul 13, 2022

    Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Steroid Refractory Graft Versus Host Disease
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    GVHD Trial in Shenzhen, Shanghai (PTCY)

    Not yet recruiting
    • GVHD
    • Shenzhen, GaungDong, China
    • +1 more
    Aug 17, 2023

    Graft-versus-host-disease, Ocular Graft-versus-host Disease Trial in Bellaire (Lifitegrast 5% Ophthalmic Solution, Refresh)

    Not yet recruiting
    • Graft-versus-host-disease
    • Ocular Graft-versus-host Disease
    • Lifitegrast 5% Ophthalmic Solution
    • Refresh
    • Bellaire, Texas
      Richard W Yee, MD PLLC
    Apr 27, 2022

    Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

    Active, not recruiting
    • Chronic Graft-versus-host-disease
    • Salt Lake City, Utah
      Huntsman Cancer Institute at University of Utah
    Jan 30, 2023

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • sargramostim
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 3, 2022

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    Has Results
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022